BHVN
Biohaven Ltd.Company with tickers: BHVN
Market Cap
$2.31B
Shares Outstanding
150,560,990
CIK
1935979
CUSIP
G1110E107
13F Activity (30d)
7 filings
4 filers
Investor Relations
Investor relations
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-28 | Antonijevic Irina |
Director | Award | 68,693 |
| 2026-04-28 | Bailey Gregory |
Director | Award | 68,693 |
| 2026-04-28 | HUGIN ROBERT J |
Director | Award | 68,693 |
| 2026-04-28 | Heffernan Michael Thomas |
Director | Award | 68,693 |
| 2026-04-28 | CHILDS JOHN W |
Director | Award | 68,693 |
| 2026-04-28 | Mehta Kishan |
Director | Award | 68,693 |
| 2026-04-28 | GREGORY JULIA P |
Director | Award | 68,693 |
| 2026-03-17 | Mehta Kishan |
Director | Gift | 17,342 |
| 2026-03-17 | Mehta Kishan |
Director | Gift | 17,342 |
| 2026-02-27 | Gentile Kimberly |
SVP, Clinical Operations | Award | 175,000 |
| 2026-02-27 | Clark George C. |
VP, Chief Accounting Officer | Award | 50,000 |
| 2026-02-27 | Coric Vlad |
Director, Chief Executive Officer | Award | 550,000 |
| 2026-02-27 | Buten Matthew |
Chief Financial Officer | Award | 175,000 |
| 2026-02-27 | Car Bruce |
Chief Scientific Officer | Award | 175,000 |
| 2026-01-05 | Clark George C. |
VP, Chief Accounting Officer | Convert | 2,500 |
| 2026-01-05 | Clark George C. |
VP, Chief Accounting Officer | Tax | 1,117 |
| 2026-01-05 | Car Bruce |
Chief Scientific Officer | Convert | 4,750 |
| 2026-01-05 | Car Bruce |
Chief Scientific Officer | Convert | 4,750 |
| 2026-01-05 | Coric Vlad |
Director, Chief Executive Officer | Convert | 14,250 |
| 2026-01-05 | Coric Vlad |
Director, Chief Executive Officer | Convert | 14,250 |
| 2026-01-05 | Buten Matthew |
Chief Financial Officer | Convert | 4,250 |
| 2026-01-05 | Gentile Kimberly |
SVP, Clinical Operations | Tax | 1,956 |
| 2026-01-05 | Gentile Kimberly |
SVP, Clinical Operations | Convert | 3,750 |
| 2026-01-05 | Coric Vlad |
Director, Chief Executive Officer | Tax | 7,430 |
| 2026-01-05 | Clark George C. |
VP, Chief Accounting Officer | Convert | 2,500 |
| 2026-01-05 | Buten Matthew |
Chief Financial Officer | Convert | 4,250 |
| 2026-01-05 | Buten Matthew |
Chief Financial Officer | Tax | 2,594 |
| 2026-01-05 | Gentile Kimberly |
SVP, Clinical Operations | Convert | 3,750 |
| 2026-01-05 | Car Bruce |
Chief Scientific Officer | Tax | 2,381 |
| 2025-11-17 | Clark George C. |
VP, Chief Accounting Officer | Buy | 17,000 |
| 2025-11-13 | Coric Vlad |
Director, Chief Executive Officer | Buy | 333,333 |
| 2025-11-13 | CHILDS JOHN W |
Director | Buy | 3,333,333 |
| 2025-11-13 | Bailey Gregory |
Director | Buy | 400,000 |
| 2025-11-13 | Coric Vlad |
Director, Chief Executive Officer | Buy | 333,333 |
| 2025-05-05 | CHILDS JOHN W |
Director | Award | 31,716 |
| 2025-05-05 | Heffernan Michael Thomas |
Director | Award | 31,716 |
| 2025-05-05 | Antonijevic Irina |
Director | Award | 31,716 |
| 2025-05-05 | GREGORY JULIA P |
Director | Award | 31,716 |
| 2025-05-05 | Mehta Kishan |
Director | Award | 31,716 |
| 2025-05-05 | HUGIN ROBERT J |
Director | Award | 31,716 |
| 2025-05-05 | Bailey Gregory |
Director | Award | 31,716 |
| 2025-03-04 | CHILDS JOHN W |
Director | Buy | 900 |
| 2025-03-04 | CHILDS JOHN W |
Director | Buy | 3,400 |
| 2025-03-04 | CHILDS JOHN W |
Director | Buy | 3,400 |
| 2025-03-04 | CHILDS JOHN W |
Director | Buy | 25,000 |
| 2025-01-05 | Coric Vlad |
Director, Chief Executive Officer | Award | 57,000 |
| 2025-01-05 | Buten Matthew |
Chief Financial Officer | Convert | 4,250 |
| 2025-01-05 | Clark George C. |
VP, Chief Accounting Officer | Award | 30,000 |
| 2025-01-05 | Coric Vlad |
Director, Chief Executive Officer | Convert | 14,250 |
| 2025-01-05 | Car Bruce |
Chief Scientific Officer | Convert | 4,750 |
Showing 1–50 of 342 transactions